Leonardo Faoro

2.2k total citations · 1 hit paper
36 papers, 1.6k citations indexed

About

Leonardo Faoro is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonardo Faoro has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonardo Faoro's work include Glioma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Leonardo Faoro is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Research Studies (4 papers). Leonardo Faoro collaborates with scholars based in United States, Brazil and Spain. Leonardo Faoro's co-authors include Ravi Salgia, Everett E. Vokes, Nazia F. Jafri, Rimas V. Lukas, M. Kelly Nicholas, Rajani Kanteti, David A. Karlin, Fang Ting Liang, Jane E. Huang and Soundararajan Krishnaswamy and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Leonardo Faoro

36 papers receiving 1.5k citations

Hit Papers

Cabozantinib for radioiodine-refractory differentiated th... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
    2021 156 citations Marcia S. Brose, Bruce Robinson et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonardo Faoro United States 16 691 686 344 248 202 36 1.6k
Rosa Fonti Italy 23 560 0.8× 489 0.7× 276 0.8× 137 0.6× 81 0.4× 65 1.6k
Robert Königsberg Austria 16 676 1.0× 536 0.8× 165 0.5× 120 0.5× 220 1.1× 31 1.5k
Susanna Cappia Italy 24 766 1.1× 651 0.9× 748 2.2× 387 1.6× 163 0.8× 56 2.0k
So Young Kang South Korea 29 895 1.3× 714 1.0× 634 1.8× 366 1.5× 625 3.1× 92 2.1k
Sergi Benavente Spain 15 931 1.3× 523 0.8× 545 1.6× 221 0.9× 127 0.6× 33 1.4k
E. Lin United States 21 811 1.2× 971 1.4× 491 1.4× 331 1.3× 350 1.7× 35 2.1k
Dakeun Lee South Korea 23 581 0.8× 603 0.9× 346 1.0× 304 1.2× 201 1.0× 74 1.4k
Keiko Funa Sweden 20 609 0.9× 716 1.0× 222 0.6× 141 0.6× 99 0.5× 37 1.6k
Isabella Morra Italy 19 296 0.4× 412 0.6× 179 0.5× 449 1.8× 69 0.3× 43 1.2k
Élodie Vauléon France 24 596 0.9× 522 0.8× 414 1.2× 199 0.8× 151 0.7× 60 1.8k

Countries citing papers authored by Leonardo Faoro

Since Specialization
Citations

This map shows the geographic impact of Leonardo Faoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonardo Faoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonardo Faoro more than expected).

Fields of papers citing papers by Leonardo Faoro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonardo Faoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonardo Faoro. The network helps show where Leonardo Faoro may publish in the future.

Co-authorship network of co-authors of Leonardo Faoro

This figure shows the co-authorship network connecting the top 25 collaborators of Leonardo Faoro. A scholar is included among the top collaborators of Leonardo Faoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonardo Faoro. Leonardo Faoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brose, Marcia S., Bruce Robinson, Steven I. Sherman, et al.. (2021). Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 22(8). 1126–1138. 156 indexed citations breakdown →
3.
Liu, Ren, Cleo E. Rolle, Yi‐Hung Carol Tan, et al.. (2013). The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target. PLoS ONE. 8(7). e67668–e67668. 56 indexed citations
4.
Cohen, Ezra E.W., Janakiraman Subramanian, Feng Gao, et al.. (2011). Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial. Clinical Lung Cancer. 13(2). 123–128. 10 indexed citations
5.
Robinson, Matthew R., Suvobroto Nandi, Leonardo Faoro, et al.. (2011). Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research. Journal of Visualized Experiments. 4 indexed citations
6.
Faoro, Leonardo, Patrick A. Singleton, Gustavo M. Cervantes, et al.. (2010). EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation. Journal of Biological Chemistry. 285(24). 18575–18585. 96 indexed citations
7.
Hainsworth, John D., Fang Ting Liang, Jane E. Huang, et al.. (2010). BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(1). 109–114. 48 indexed citations
8.
Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Leonardo Faoro, et al.. (2009). The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research. 69(7). 3021–3031. 211 indexed citations
9.
Kanteti, Rajani, Vidya Nallasura, Sivakumar Loganathan, et al.. (2009). PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription. Laboratory Investigation. 89(3). 301–314. 82 indexed citations
10.
Faoro, Leonardo, Gustavo M. Cervantes, Essam El‐Hashani, & Ravi Salgia. (2009). MET Receptor Tyrosine Kinase. Journal of Thoracic Oncology. 4(11). S1064–S1065. 13 indexed citations
11.
Salgia, Ravi, et al.. (2009). MET/PKCß expression correlate with metastasis and inhibition is synergistic in lung cancer. Journal of Carcinogenesis. 8(1). 15–15. 1 indexed citations
12.
Siddiqui, Shahid, Sivakumar Loganathan, Soundararajan Krishnaswamy, et al.. (2008). C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes. Cancer Biology & Therapy. 7(6). 856–863. 23 indexed citations
13.
14.
Faoro, Leonardo, Ayalew Tefferi, & Ruben A. Mesa. (2005). Long‐term analysis of the palliative benefit of 2‐chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia. European Journal Of Haematology. 74(2). 117–120. 37 indexed citations
15.
Bleggi‐Torres, Luiz Fernando, Emerson L. Gasparetto, Leonardo Faoro, et al.. (2001). Pleomorphic xanthoastrocytoma: Report of a case diagnosed by intraoperative cytopathological examination. Diagnostic Cytopathology. 24(2). 120–122. 7 indexed citations
16.
Medeiros, Carlos Roberto de, Luiz Fernando Bleggi‐Torres, Leonardo Faoro, et al.. (2001). Cavernous sinus thrombosis caused by zygomycosis after unrelated bone marrow transplantation. Transplant Infectious Disease. 3(4). 231–234. 8 indexed citations
17.
Gasparetto, Emerson L., et al.. (2000). Hemangioblastomas: achados clínicos, epidemiológicos e anatomopatológicos em 14 casos. Arquivos de Neuro-Psiquiatria. 58(2A). 310–314. 2 indexed citations
18.
Gasparetto, Emerson L., et al.. (2000). Neurocisticercose: estudo clínico e patológico de 27 casos de necrópsia. Arquivos de Neuro-Psiquiatria. 58(3B). 883–889. 10 indexed citations
19.
Reis‐Filho, Jorge S., Leonardo Faoro, Carla Carrilho, Luiz Fernando Bleggi‐Torres, & Fernando Schmitt. (2000). Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with world health organization grade 2 oligodendroglioma. Cancer. 88(4). 862–869. 27 indexed citations
20.
Scola, Rosana Hermínia, et al.. (1999). Síndrome do desfiladeiro torácico tipo neurogênico verdadeiro: relato de dois casos. Arquivos de Neuro-Psiquiatria. 57(3A). 659–665. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Fonti Breakdown of academic impact, for papers by Robert Königsberg Breakdown of academic impact, for papers by Susanna Cappia Breakdown of academic impact, for papers by So Young Kang Breakdown of academic impact, for papers by Sergi Benavente Breakdown of academic impact, for papers by E. Lin Breakdown of academic impact, for papers by Dakeun Lee Breakdown of academic impact, for papers by Keiko Funa Breakdown of academic impact, for papers by Isabella Morra Breakdown of academic impact, for papers by Élodie Vauléon
Rankless by CCL
2026